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Preface 
David A. Norris, Jouni Uitto, Ervin Epstein, Jr., and Joseph Yohn 
T he 42nd Annual Symposium on the Biology of Skin addressed "The Genetics of Skin Disease" in Snow­mass Village, Colorado from July 24 to 28, 1993. This year's meeting presented the opportunity to dis­cuss how modem approaches to molecular genetics 
and molecular biology have been applied to understanding the 
mechanisms of skin disease. It also allowed us to explore the poten­
tial for using approaches in gene therapy to correct genetic defects in 
structural proteins. The meeting brought together biochemists; 
molecular, cellular, and developmental biologists; ultrastructural 
biologists; pharmacologists; molecular geneticists; cutaneous biolo­
gists; and academic and clinical dermatologists, geneticists, and pe­
diatricians. Scientists from academic departments, research insti­
tutes, biotechnology companies, and the pharmaceutical industry 
were all well represented. Twenty three speakers and sixteen poster 
presenters participated in the meeting. 
By design, the Symposium on the Biology of Skin has brought 
together cutaneous biologists with other scientists in basic and clini­
cal research fields to consider in detail one aspect of cutaneous biol­
ogy. These meetings have served as a forum where established and 
developing scientists, as well as students and trainees, could all meet 
to discuss a single topic in detail, bringing to bear their different 
perspectives on the problem at hand. These meetings and their 
published proceedings have shown how the skin can be a model for 
the study of universal mechanisms in biology. By combining the 
approaches of scientists outside of the normal sphere of cutaneous 
biology with those accustomed to using the skin as a means to study 
biology, this symposium has often produced fresh perspectives and 
launched new research adventures. 
It is an opportune time to examine "The Genetics of Skin Dis­
ease." By a combination of fortune and concerted effort in govern­
ment, funding for basic research in the structural disorders of the 
skin such as epidermolysis bullosa has directed application of mod­
em techniques in molecular genetics to the study of these diseases. 
The first part of this meeting considered diseases involving genetic 
defects in structural proteins of the epidermis and dermis. Pioneer­
ing ultrastructural studies that helped to define the location of the 
abnormal proteins in the disorders of keratinization and in epider­
molysis bullosa were proved correct by elegant studies that localized 
molecular defects in simplex, junctional, dominant dystrophic, and 
recessive dystrophic epidermolysis bullosa and in epidermolytic hy­
perkeratosis. Elegant research has also defined genetic mutations in 
Ehlers-Danlos syndromes, Marfan syndrome, and pseudoxanthoma 
elasticum. 
The identification of the precise mutations and the altered pro­
teins that characterize this group of diseases of the dermis and epider­
mis raise the intriguing possibility that gene therapy approaches may 
be applied to reverse the phenotype of these diseases. These possibil­
ities were discussed thoroughly, considering especially the facility 
of using transfected keratinocytes as a means of delivering the trans­
genes. In addition, modem techniques such as homologous recom­
bination and the use of anti-sense approaches or ribozymes to inhibit 
transcription and expression of the products of mutated genes were 
discussed. We are on the threshold of gene therapy trials to correct 
the central genetic defects in several forms of epidermolysis bullosa. 
The topic of the Symposium shifted from structural protein mu­
tations to malignant transformation. The interaction of genetic de­
terminants of ultraviolet light sensitivity and mutations in a limited 
number of oncogenes and tumor suppressor genes is associated with 
the development of melanoma and non-melanoma skin cancers. 
These diseases are important medical problems and also provide 
important models for the study of multistage carcinogenesis and 
UV-induced transformation. Identification of the susceptibility 
genes for melanoma and nevoid basal cell carcinoma syndrome will 
help us understand the induction of cancer; modulation of mutated 
genes in these tumors may allow us to alter their aggressiveness. 
The genetics of other complex processes in the skin are also being 
better understood through application of techniques of modem ge­
netics. The genetics of pigmentation has moved in a particularly 
rapid fashion in the past five years as the genetic bases for mouse and 
human models of dyspigmentation have been characterized. Au­
toimmune diseases involving the skin are complex polygenic pro­
cesses whose genetic character is now being appreciated. Finally 
psoriasis, one of the most common and fascinating skin diseases, is 
also being approached genetically, with great promise for identify­
ing the genetic loci that determine the psoriatic phenotype. 
The organizers of the Symposium on the Biology of Skin have 
designed a meeting true to the principles established by Dr. William 
Montagna and continued by Dr. Kirk Wuepper. The Symposium 
continues to be a crucible for the amalgamation of different ap­
proaches and ideas and for creating better understanding of basic 
biologic processes in the skin. This supplement in The Journal of 
Investigative Dermatology allows us to extend the influence of this 
gathering to the journal subscribers who encompass the corpus of 
cutaneous biology. 
We wish to thank Ms. Beverly Polt and Ms. Cheryl Burns who 
organized the meeting and the affairs of Cutaneous Biology Foun­
dation during the year. We also appreciate the support of the of­
ficers and Directors of the Cutaneous Biology Foundation who 
oversee the planning and financial support of the meeting. This 
conference has been supported for the past 27 years by a conference 
grant from the National Institutes of Health, and has also been 
faithfully supported by a number of firms in the pharmaceutical and 
cosmetics industry. We also wish to thank the Editor of the jID, Dr. 
Edward O'Keefe, for his support for publication of the proceedings 
and for preparing the manuscripts for publication. 
These proceedings demonstrate clearly how modem approaches 
in genetics have allowed us to better understand the mechanism of a 
variety of important skin diseases, from mechanobullous disorders 
to malignancy to autoimmunity and inflammatory dermatoses. 
These diseases may be life-threatening, incapacitating, or merely a 
major impediment to a comfortable life. Their incidence ranges 
from the common to the rare. Not only will we be able to better 
understand their mechanisms and design better treatments for their 
control, but we may even reverse their basic nature by the applica­
tion of evolving gene therapy techniques. 
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